SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-054893
Filing Date
2024-06-21
Accepted
2024-06-21 17:28:00
Documents
15
Period of Report
2024-06-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0208292-8k_10xcap3.htm   iXBRL 8-K 34435
2 MUTUAL TERMINATION OF MERGER AGREEMENT, DATED JUNE 21, 2024, BETWEEN 10X III, ME ea020829201ex10-1_10xcap3.htm EX-10.1 32331
  Complete submission text file 0001213900-24-054893.txt   305235

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE vcxb-20240621.xsd EX-101.SCH 4221
4 XBRL DEFINITION FILE vcxb-20240621_def.xml EX-101.DEF 27375
5 XBRL LABEL FILE vcxb-20240621_lab.xml EX-101.LAB 38062
6 XBRL PRESENTATION FILE vcxb-20240621_pre.xml EX-101.PRE 25995
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0208292-8k_10xcap3_htm.xml XML 7667
Mailing Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007
Business Address 1 WORLD TRADE CENTER FLOOR 85 NEW YORK NY 10007 (212) 257-0069
10X Capital Venture Acquisition Corp. III (Filer) CIK: 0001848948 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41216 | Film No.: 241061479
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)